UK markets open in 1 hour 50 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,266.00+13.00 (+0.16%)
At close: 4:45PM BST
Sign in to post a message.
  • C
    CM
    Well then, looks like my profitable shares in Alexion will turn into azn shares tomorrow. Golly gee I sure am excited to get shares in such a large and well known pharma company. Guess I better take a look and see what the financials look like but I'm sure it's fine...There sure are a lot of people complaining on the message board though. Okay here we are: price action, p/e, profits, earnings beats, earnings projections it's all here and...oh...oh no...no no no. Well they must have good projected growth and...okay well the underlying assets surely are worth something...well they at least should have low debt levels because otherwise that would be absurd...I see. Well..this has been disappointing.
  • s
    sexton
    (http://Rightpicker.com) is a must for any trader. Their watchlist which covers pre-market movers is one of the best researched in the industry. I don’t start trading without reading their daily email each morning!
  • m
    man
    The snail climbs now.
    High volume in other stock rising like rocket, see meme stock.
    $100 just 3 days.
    But I don't know the case in AZN.
    Any ideas?
  • m
    man
    High volume but don't move. What's it mean?
    A lot of people buy or a lot of people sell?
  • E
    E A
    In regard to vaccine struggles:

    “Investors should look past this, and remember that AstraZeneca (ticker: AZN), which is listed in London while its American Depositary Receipts trade in the U.S., isn't just a vaccine company. It's a specialist in cancer treatments, and it supplies medicine for a host of other diseases. It has a strong pipeline, a growing number of $1 billion blockbuster drugs and, with now, EU and U.S. approval of its acquisition of Alexion Pharmaceuticals (ALXN), a promising new rare-diseases division.

    A handful of its recently approved treatments could lift the company's bottom line and stock price higher in the coming years. AstraZeneca's "impressive" revenue and profit trajectory is compelling relative to its European pharma peers, analysts at Jefferies wrote in a research note.”

    Barron’s
  • C
    Cloggervic
    I posted on the ALXN board that I checked my account just after midnight to see if the merger had journaled over and found I had suddenly acquired a margin purchasing power of $76m with $22m withdrawable. hahaha!
    I hoped the night shift would have it right by morning and they have, apart from the gain/loss calculation which I am sure is a challenge for the IT nerds.
    I would want my account to show actual gain or loss on the merger while the tax page would show tax gain or loss, which is likely not the same.
    Here is the way the calculation is done:
    The value of AZN received for 1 ALXN is 2.1243×$57.77 = $122.72.
    The total considerstion received is $122.72 +$60 = $182.72
    Your actual gain or loss is the difference between your ALXN basis and $182.72

    Your taxable gain or loss hss to be calculated separately for shares held short term and shares held long term.

    You can either lump all your long term shares together (ditto short term) or else do it on a tax lot basis which will give a different result. Pick whichever is best. S tax lot is all shares bought on the same date.
    If the basis of a lot is less than $122.72 then taxable gain is the lesser of the difference, or $60.
    If the badis us between 223.72 and 182.72 there is no tsxable gain. If the basis is over 182.72 there is a taxable loss.
    Simple program in FORTRAN!
  • d
    dennis
    Expecting 19.9% growth
  • C
    Carlos
    I like that it is a company that actually has multiple helpful to health products and is constantly looking for ways to serve others. Lungs etc
  • T
    Twitter hanli1105
    $AZN announced the European Commission has approved their merger with $ALXN, expected to close in 2021Q3. This will make $AZN a stronger presence in rare diseases, strengthening their position in immunology.
  • J
    Jinho
    Do you guys who was holding an ALXN stock get a AZN stocks?
  • S
    Sir Royston
    Third AZN dose boosts immunity. This vaccine will make money for AZN when the not-for-profit period ends.
  • C
    Cloggervic
    What do you think:

    Will AZN declare and pay the next dividend before or after the merger?

    Here is my reasoning:

    It will be before.
    If it were after, there would be many more shares to pay it to.
    Also, some ALXN shareholders would pay more tax on the merger proceeds

    Therefore since next ex div date is around aug 25, I would guess the merger date will be between mon sept 27 and thurs sept 30 and not into Q4, as they predicted a Q3 merger and that is important for funds holding AZN or ALXN.
  • M
    MP
    Gap is closing @$56.85. Don’t buy before. Good chance it might go lower.
  • N
    Nathan
    As of July 1 occurring to the world health organization. AZN has the sole ability to determine if the pandemic is still on going or if it's over. if it's still ongoing they will continue to donate them. however if they say it's over then they can sell the vaccine for retail. This is not a conspiracy nor will I give you a link. Find it yourself it is not hard.
  • C
    Cloggervic
    ALXN gone. But AZN and $60 not yet appeared. Result: Margin call! Potential class action if not rectified pronto.
  • S
    SB formely MB
    CYDY holder here, not here to pimp but have a question. Within the last last couple weeks our CMO was in London and it’s widely known CYDY is looking for a BP partner (was confirmed in their last shareholder Cc) for their long hauler trail which they just announced outstanding phase 2 results. It’s a 15 billion market and we are too small and can’t screw this up. CYDY and their drug Leronlimab are the only ones that are this far along for long hauler. You guys think this would be something AZN is considering? Thanks.
  • s
    scott
    Alexion is going to add about $5 billion in FCF next year…need I say more?
  • M
    Myles
    crickets when the stock goes up...
  • S
    Sir Royston
    finally sold all my AZN, made 11% profit. And all while the trolls were trying to discredit AZN. Thank you trolls, I'm you played some small part in my success story. All that remains now is for the SP to dip so I can buy some more, oh yeah.